You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 15, 2025

Profile for Argentina Patent: 065931


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Argentina Patent: 065931

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
⤷  Get Started Free Jun 14, 2031 Pf Prism Cv INLYTA axitinib
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Detailed Analysis of the Scope, Claims, and Patent Landscape for Argentina Patent AR065931

Last updated: July 31, 2025

Introduction

Patent AR065931 pertains to a pharmaceutical invention filed and granted in Argentina. To optimize strategic decisions, it is imperative to dissect its scope, claims, and position within the broader patent landscape. This detailed review offers insights into the patent's legal boundaries, its technological coverage, and its competitive environment.


Patent Overview

AR065931, granted by the National Institute of Industrial Property of Argentina (INPI), concerns a specific formulation, compound, or method related to a pharmaceutical product. Although detailed patent claims document is not always publicly available, typical Argentine patents follow a structured approach, covering compositions, uses, methods of preparation, and novel formulations.


Scope of the Patent

Technical Field and Purpose

AR065931 falls within the scope of pharmaceutical compositions, likely targeting a specific therapeutic area such as oncology, infectious diseases, or chronic conditions, depending on the precise claims. The scope typically encompasses:

  • Novel active ingredient combinations
  • Innovative delivery mechanisms
  • Unique formulations or dosage forms
  • Methods of synthesis or use

Scope Boundaries

The scope's breadth depends mainly on the patent’s claims, which determine what is protected and what is excluded. A broad scope might include various derivatives or analogs, while a narrow scope concentrates on specific compounds or methods.


Claims Analysis

Claims Structure

Argentine patents generally comprise:

  • Independent Claims: Define the broadest invention, often covering the core compound, formulation, or method.
  • Dependent Claims: Add specific features, such as particular substitutions, concentrations, or methods.

Key Elements in the Claims

Based on typical pharmaceutical patents, the claims in AR065931 likely include:

  • Compound-specific Claims: Covering the chemical entity itself.
  • Method of Use Claims: Covering a therapeutic application.
  • Formulation Claims: Covering specific excipients or delivery systems.
  • Process Claims: Covering synthesis or manufacturing steps.

Scope of Protection

The scope's strength hinges on claim clarity and novelty:

  • Novelty: The claims should specify features that distinguish from prior art.
  • Inventive Step: Claims must involve an inventive leap over existing solutions.
  • Industrial Applicability: The claims cover subject matter capable of industrial use, essential for patentability in Argentina.

Patent Landscape Context

Existing Patent Environment

Argentina’s pharmaceutical patent landscape primarily consists of:

  • Patents filed by multinational corporations for innovative drugs.
  • Local patents for formulations or methods tailored to regional needs.
  • Patent families covering the same invention filed internationally under Patent Cooperation Treaty (PCT), but with regional distinctions.

Prior Art and Patent Overlap

The patent landscape around AR065931 involves:

  • Similar compounds or combinations patented in South America, Latin America, or globally.
  • Prior art that might relate to the same chemical class or therapeutic indication.
  • Freedom-to-operate considerations relevant to competitors and licensees.

Relevant Patent Families

AR065931 may be part of an international patent family, extending protection to jurisdictions like Brazil, Chile, or broader Latin America. The scope within these jurisdictions influences market exclusivity.

Legal Status and Opposition

  • Since AR065931 is granted, its validity is presumed unless challenged via opposition proceedings.
  • Argentina provides mechanisms for third-party observations or oppositions, especially within the first year of grant.

Strategic Implications

Protection Strengths

  • Well-drafted claims covering novel aspects of the compound or formulation bolster enforceability.
  • Specific claims offer legal certainty against infringers in Argentina.

Protection Limitations

  • Narrow claims may limit the exclusivity scope.
  • Overlap with prior art could weaken patent validity or inspire design-around strategies.

Competitive Landscape

  • Monitoring for similar patents or patent applications in Argentina informs potential patent infringement risks.
  • Licensing opportunities may arise where the patent’s claims overlap with regional innovation.

Conclusion

AR065931 offers pharmaceutical patent protection within the Argentine jurisdiction, with scope rooted in its claims covering specific compounds, formulations, or methods. Its strength depends on claim breadth, inventive distinction, and alignment with prior art. Understanding its position within the Argentine patent landscape aids in strategic decision-making regarding market entry, licensing, or litigation.


Key Takeaways

  • Scope Precision: The patent's claims define the core protection; broader claims afford greater exclusivity but require clear novelty and inventiveness.
  • Landscape Awareness: Parallel filings in Latin America could influence the patent’s territorial breadth and enforceability.
  • Legal Validity: While granted, the patent remains susceptible to oppositions; regular monitoring is advised.
  • Market Strategy: The patent's protective scope informs licensing and infringement strategies, especially in competitive or emerging markets.
  • Innovation Focus: To maintain patent robustness, future filings should emphasize clear inventive steps and comprehensive coverage.

FAQs

1. How does Argentine patent AR065931 compare to international patents in the same field?
AR065931 likely focuses on region-specific claims; international patents, especially those filed under PCT, may have broader or differently scoped claims. Compatibility and overlap determine freedom-to-operate and potential licensing.

2. Can AR065931 be challenged or invalidated in Argentina?
Yes. Third parties can file oppositions within a specific period post-grant, challenging its validity based on prior art or insufficient inventive step.

3. What considerations influence the strength of the patent's claims?
Clarity, specificity, novelty, inventiveness, and non-obviousness are critical factors impacting claim strength.

4. How does regional patent law affect the scope of pharmaceutical patents in Argentina?
Argentine law emphasizes inventive step and industrial applicability. As a civil law jurisdiction, patent scope is strictly interpreted against prior art, affecting claim breadth.

5. What strategies optimize patent protection in Latin America?
Filing regional patent applications covering multiple jurisdictions, ensuring claims are well-drafted and novel, and actively monitoring the patent landscape maximize protection.


References

  1. Argentine Patent Law (Law No. 24,481).
  2. INPI Argentina Patent Database.
  3. World Intellectual Property Organization (WIPO) Patentscope database entries for similar patents.
  4. Official patent documents and legal analyses of AR065931.
  5. Regional patent landscape reports relevant to Latin American pharmaceutical patents.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.